These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2163135)

  • 1. The role of IA antigen+ epidermal cells in rejection of rat skin equivalent grafts.
    Lerner-Tung MB; Hull BE
    Transplantation; 1990 Jun; 49(6):1181-4. PubMed ID: 2163135
    [No Abstract]   [Full Text] [Related]  

  • 2. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoelectron microscopic analysis of Ia antigen expression in rat skin during limb allograft rejection.
    Mohtai M; Sugioka Y; Hotokebuchi T; Arai K; Hirana A; Wasano K; Kaibara N
    Am J Pathol; 1990 Feb; 136(2):285-95. PubMed ID: 2154927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultured epithelium allografts: Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection.
    Rouabhia M; Germain L; Bélanger F; Auger FA
    Transplantation; 1993 Aug; 56(2):259-64. PubMed ID: 8102819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
    Benham AM; Fabre JW
    Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
    [No Abstract]   [Full Text] [Related]  

  • 7. Rejection of dendritic-cell-depleted epithelial-cultured allografts.
    Rouabhia M; Germain L; Belanger F; Auger FA
    Transplant Proc; 1992 Dec; 24(6):3014. PubMed ID: 1466038
    [No Abstract]   [Full Text] [Related]  

  • 8. Ia antigens and epidermal Langerhans cells.
    Streilein JW; Bergstresser PR
    Transplantation; 1980 Nov; 30(5):319-23. PubMed ID: 7006163
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.
    Ijzermans JN; Bouwman E; Jeekel J; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1941-2. PubMed ID: 2117821
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
    J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
    Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of Ia antigen on epidermal keratinocytes after the grafting of normal skin to nude mice.
    Daynes RA; Emam M; Krueger GG; Roberts LK
    J Immunol; 1983 Apr; 130(4):1536-9. PubMed ID: 6339613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Langerhans cell.
    Wolff K; Stingl G
    J Invest Dermatol; 1983 Jun; 80 Suppl():17s-21s. PubMed ID: 6343515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of class II antigen-expressing cells in corneal allograft immunity.
    Gebhardt BM
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2254-60. PubMed ID: 2242991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.